申请人:Jonczyk Alfred
公开号:US20120295902A1
公开(公告)日:2012-11-22
Novel hetaryl-[1,8]naphthyridine derivatives of formula (I)
wherein R1, R2, W
1
, W
3
, W
5
and W
6
have the meaning according to claim
1
, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors.
新型杂芳基-[1,8]萘啶衍生物的化学式(I),其中R1、R2、W1、W3、W5和W6的含义如权利要求书中所述,是ATP消耗蛋白的抑制剂,可用于治疗肿瘤。